European Journal of Cancer
Volume 45, Issue 1 , Pages 65-73 , January 2009

Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings

  • Mario Mandalà

      Affiliations

    • Unit of Medical Oncology, Ospedali Riuniti, 24100 Bergamo, Italy
    • Corresponding Author InformationCorresponding author: Tel.: +39 35269858; fax: +39 35266849.
    • ,
  • Sandro Barni

      Affiliations

    • Division of Medical Oncology, Treviglio Hospital, Treviglio Division of Medical Oncology, Italy
    • ,
  • Irene Floriani

      Affiliations

    • Department of Oncology, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy
    • ,
  • Luciano Isa

      Affiliations

    • Department of Medical Oncology, Ospedale Serbelloni, Gorgonzola (MI), Italy
    • ,
  • Giuseppe Fornarini

      Affiliations

    • Department of Medical Oncology, San Martino Hospital, Genova, Italy
    • ,
  • Maurizio Marangolo

      Affiliations

    • Istituto Oncologico Romagnolo, Department of Oncology, Santa Maria delle Croci Hospital, Ravenna, Italy
    • ,
  • Stefania Mosconi

      Affiliations

    • Unit of Medical Oncology, Ospedali Riuniti, 24100 Bergamo, Italy
    • ,
  • Domenico Corsi

      Affiliations

    • Department of Oncology, Fatebenefratelli Hospital, Roma, Italy
    • ,
  • Eliana Rulli

      Affiliations

    • Department of Oncology, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy
    • ,
  • Luciano Frontini

      Affiliations

    • Division of Medical Oncology, San Gerardo Hospital, Monza, Italy
    • ,
  • Enrico Cortesi

      Affiliations

    • Medical Oncology B, Policlinico Umberto I Hospital, ‘La Sapienza’ University, Rome, Italy
    • ,
  • Alberto Zaniboni

      Affiliations

    • Fondazione poliambulanza, Brescia, Italy
    • ,
  • Massimo Aglietta

      Affiliations

    • U.O. Oncologia Medica IRCCS, Candiolo, Italy
    • ,
  • Roberto Labianca

      Affiliations

    • Unit of Medical Oncology, Ospedali Riuniti, 24100 Bergamo, Italy
    • On Behalf of GISCAD (Italian Group for the Study of Gastrointestinal Cancer).

Received 21 August 2008 ,Accepted 5 September 2008.

  • Image Result

    Thrombosis free interval in patients treated with continuous versus intermittent FOLFIRI (5FU, Irinotecan, folinic acid) schedule.

    Thrombosis free interval in patients treated with continuous versus intermittent FOLFIRI (5FU, Irinotecan, folinic acid) schedule.

  • Image Result

    Progression free survival for patients with or without venous thromboembolism.

    Progression free survival for patients with or without venous thromboembolism.

  • Image Result

    Overall survival for patients with or without venous thromboembolism.

    Overall survival for patients with or without venous thromboembolism.

PII: S0959-8049(08)00704-1

doi: 10.1016/j.ejca.2008.09.005

European Journal of Cancer
Volume 45, Issue 1 , Pages 65-73 , January 2009

Article Tools

* Image Usage & Resolution